Credit Suisse initiated coverage on SOPHiA GENETICS SA with a new price target
$SOPH
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Credit Suisse initiated coverage of SOPHiA GENETICS SA with a rating of Neutral and set a new price target of $2.00